Judge Delays DEA’s Marijuana Rescheduling Hearing, List of Those Set to Testify Released

The Drug Enforcement Administration (DEA) has postponed its hearing on their proposal to reschedule marijuana until early 2025, citing a need for more detailed information on the participants set to testify.

Although DEA Administrator Anne Milgram approved over 20 participants for the agency’s rescheduling hearing, Chief Administrative Law Judge (ALJ) John Mulrooney issued a preliminary order Thursday, requesting additional information from witnesses, including their availability for a potential hearing in January or February. Participants are being told to respond by November 12.

While an initial meeting will still occur on December 2, the ALJ clarified that no testimony or evidence collection will occur during that session, but instead will take place during the January or February meeting yet to be scheduled.


Following an over year-long review, the Justice Department in May recommended rescheduling marijuana from Schedule I to Schedule III. This led to a 60-day public comment period in which over 40,000 comments were submitted, with over 90% in support of either rescheduling marijuana or going further and descheduling it.

The full list of those set to testify at the upcoming hearing can be found below:

  • American College of Occupational and Environmental Medicine (Dr. Natalie Hartenbaum)
  • Veterans Initiative 22 (Shanetha Lewis)
  • International Academy on the Science and Impact of Cannabis (Dr. Roneet Lev)
  • Saint Michael’s College (Dr. Ari Kirshenbaum)
  • Dr. Phillip Drum
  • National Cannabis Industry Association (Aaron Smith, CEO; Michelle Rutter Friberg, Chief Lobbyist)
  • Drug Enforcement Administration of Federal Narcotics Agents (Marshall Fisher)
  • State of Connecticut (Erin Gorman Kirk, Cannabis Ombudsman)
  • Smart Approaches to Marijuana (Patrick Philbin)
  • National Sheriffs’ Association (No specific individual identified)
  • Village Farms International (Shane Pennington, Administrative Law Attorney)
  • Cannabis Bioscience International Holdings (John Jones, Treasurer and Director)
  • Tennessee Bureau of Investigation (Kim Litman)
  • Dr. Kenneth Finn
  • The Commonwealth Project (Katy Green, Lobbyist with Platinum Advisors)
  • Attorney General Mike Hilgers for the State of Nebraska (Attorney General Mike Hilgers)
  • Hemp for Victory (Robert Head, Corey Burchman, Darinia Douchi, Victor Bohm)
  • Massachusetts Cannabis Advisory Board (Ellen Brown, Chair of the Research Subcommittee)
  • Community Anti-Drug Coalitions of America (Sue Thau)
  • The Doc App, dba My Florida Green (Nicholas Garulay, President and CEO; Jason Castro, In-House Counsel)
  • National Drug and Alcohol Screening Association (Jo McGuire)
  • Cannabis Industry Victims Educating Litigators (David Evans Sr., Counsel)
  • National Transportation Safety Board (Jennifer Homendy, Chair)
  • International Association of Chiefs of Police (No specific individual identified)
  • American Academy of Hospice and Palliative Medicine (Dr. Chad Kollas)

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

More articles from The Marijuana Herald can be found below.

Study: Psilocybin Treatment May Benefit Those With PTSD

Study: Psilocybin Treatment May Benefit Those With PTSD

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Virginia Lawmaker Files Bill to Legalize Licensed Recreational Cannabis Sales, Increase Possession Limit

Virginia Lawmaker Files Bill to Legalize Licensed Recreational Cannabis Sales, Increase Possession Limit

New Jersey Bill Would Create State-Funded Subsidy to Cut Medical Marijuana Costs for Medicaid Patients

New Jersey Bill Would Create State-Funded Subsidy to Cut Medical Marijuana Costs for Medicaid Patients

Survey Finds 59% of Indiana Voters Support Legalizing Recreational Cannabis, 84% Support Medical

Survey Finds 59% of Indiana Voters Support Legalizing Recreational Cannabis, 84% Support Medical

Seven of Eight Remaining NFL Playoff Teams Come From States Where Recreational Marijuana Is Legal

Seven of Eight Remaining NFL Playoff Teams Come From States Where Recreational Marijuana Is Legal

Washington Bill Would Replace 37% Marijuana Excise Tax With Weight- and Potency-Based Rates

Washington Bill Would Replace 37% Marijuana Excise Tax With Weight- and Potency-Based Rates

Legal Cannabis Sales in U.S. Pass $2.3 Billion in December, $27 Billion in 2025

Legal Cannabis Sales in U.S. Pass $2.3 Billion in December, $27 Billion in 2025

Gelteq Reports Preclinical Results Showing Oral Gel Boosts CBD Absorption

Gelteq Reports Preclinical Results Showing Oral Gel Boosts CBD Absorption

Glass House and University of California Berkeley Secure $1.8 Million State Grant to Study Marijuana Crop Yields

Glass House and University of California Berkeley Secure $1.8 Million State Grant to Study Marijuana Crop Yields

Smart & Safe Florida Raises More Than $52 Million to Support 2026 Marijuana Legalization Initiative

Smart & Safe Florida Raises More Than $52 Million to Support 2026 Marijuana Legalization Initiative

Study: CBD Shown to Reduce Seizures Across Wide Range of Treatment-Resistant Epilepsies

Study: CBD Shown to Reduce Seizures Across Wide Range of Treatment-Resistant Epilepsies

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders